MUIR TORRE SYNDROME: THE ROLE OF IHC AND GENOTYPING IN SEBACEOUS NEOPLASIA TO FACILITATE PREVENTION STRATEGIES IN COLORECTAL AND ENDOMETRIAL CANCER

Abstract

Sebaceous neoplasia (SN), may be an early warning sign for Lynch syndrome (LS), an inherited cancer predisposition caused by mutations in a group of genes. There are high lifetime risks of bowel and uterine cancer, for which there are effective risk management plans if the risk is known. Clinicians are challenged by the role of SN in identifying LS. At present, it is hard to differentiate. We aim to determine features to improve the diagnosis of LS carriers.